Impact of metabolic and cardiovascular diseases on the course of COVID-19

Абдиева Гулнора Алиевна, Ташкенбаева Элеонора Негматовна

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali · 2022-yil

Annotatsiya

The article describes the impact of cardio-metabolic comorbidities on the severity and course of COVID-19. A total of 116 patients were included in the study. The highest risk of developing critical or fatal COVID-19 disease was in patients with underlying cardiovascular disease [OR: 3.44, 95% CI: 2.65–4.48], followed by chronic lung disease, hypertension, and diabetes mellitus. Of the total cases, 64% had one of four comorbidities (diabetes, hypertension, chronic lung disease, or cardiovascular disease), the most common being hypertension, with a combined prevalence of 27%. The presence of comorbidities such as cardiovascular disease, chronic lung disease, hypertension, and diabetes mellitus resulted in a higher risk of developing critical or fatal COVID-19 disease, with the highest risk occurring with underlying cardiovascular disease.

Maqola ma’lumotlari
MualliflarАбдиева Гулнора Алиевна, Ташкенбаева Элеонора Негматовна
JurnalJournal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali
NashriyotСамарқанд давлат тиббиёт университети
Nashr sanasi2022-06-29
Jild3
Son2
TilIngliz
Ilmiy sohaTibbiyot
Indeksga qo‘shilgan2026-08-26

Kalit so‘zlar

COVID-19, SARS-CoV-2, гипертония, сахарный диабет, сердечно-сосудистые заболевания., COVID-19, SARS-CoV-2, hypertension, diabetes mellitus, cardiovascular disease., COVID-19, SARS-CoV-2, gipertoniya, qandli diabet, yurak-qon tomir kasalliklari.

Ilmiy soha

Iqtibos keltirish

APAАбдиева Гулнора Алиевна, & Ташкенбаева Элеонора Негматовна (2022). IMPACT OF METABOLIC AND CARDIOVASCULAR DISEASES ON THE COURSE OF COVID-19. Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 3(2). https://www.tadqiqot.uz/index.php/cardio/article/view/4994
GOST (OAK)Абдиева Гулнора Алиевна, Ташкенбаева Элеонора Негматовна IMPACT OF METABOLIC AND CARDIOVASCULAR DISEASES ON THE COURSE OF COVID-19 // Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali. – 2022. – T. 3, № 2.
MLAАбдиева Гулнора Алиевна, and Ташкенбаева Элеонора Негматовна. “IMPACT OF METABOLIC AND CARDIOVASCULAR DISEASES ON THE COURSE OF COVID-19.” Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 3(2), 2022. https://www.tadqiqot.uz/index.php/cardio/article/view/4994
ChicagoАбдиева Гулнора Алиевна, and Ташкенбаева Элеонора Негматовна. “IMPACT OF METABOLIC AND CARDIOVASCULAR DISEASES ON THE COURSE OF COVID-19.” Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 3(2) (2022). https://www.tadqiqot.uz/index.php/cardio/article/view/4994
HarvardАбдиева Гулнора Алиевна, and Ташкенбаева Элеонора Негматовна (2022) ‘IMPACT OF METABOLIC AND CARDIOVASCULAR DISEASES ON THE COURSE OF COVID-19’, Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 3(2). https://www.tadqiqot.uz/index.php/cardio/article/view/4994
BibTeX
@article{article2022,
  title = {IMPACT OF METABOLIC AND CARDIOVASCULAR DISEASES ON THE COURSE OF COVID-19},
  author = {Абдиева Гулнора Алиевна and Ташкенбаева Элеонора Негматовна},
  journal = {Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali},
  year = {2022},
  volume = {3},
  number = {2},
  url = {https://www.tadqiqot.uz/index.php/cardio/article/view/4994}
}

Boshqa maqola uchun iqtibos tayyorlash

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali jurnalidan boshqa maqolalar

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali — barcha maqolalar · 2022-yil arxivi

Абдиева Гулнора Алиевна — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari